Twist Bioscience (NASDAQ:TWST – Get Free Report) will announce its earnings results before the market opens on Friday, August 4th. Analysts expect the company to announce earnings of ($1.14) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Twist Bioscience (NASDAQ:TWST – […]
Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]
Nikko Asset Management Americas Inc. grew its position in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 15.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,401,914 shares of the company’s stock after acquiring an additional 467,881 shares during […]
Twist Bioscience Co. (NASDAQ:TWST – Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among […]
AEGON ASSET MANAGEMENT UK Plc acquired a new position in Twist Bioscience Co. (NASDAQ:TWST – Get Rating) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 328,551 shares of the company’s stock, valued at approximately $4,948,000. AEGON ASSET MANAGEMENT UK Plc owned about 0.58% of […]